AstraZeneca will invest 2 billion USD in Summit Therapeutics and carry out joint cancer research.
智通财经2026/09/29 00:11Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
According to reports, Summit Therapeutics (SMMT) stated on Monday that the British pharmaceutical company AstraZeneca (AZN) will invest $2 billion in the company and collaborate on a series of studies to test the efficacy of combining the cancer treatment drugs from both parties.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
